Safety, tolerability, and immunogenicity of WGc-043 in subjects with EBV-positive cancers: Results from an investigator-initiated trial.
| Publicado en: | Journal of Clinical Oncology Vol. 42; pp. 139 - 159 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2024 Supplement
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |